<DOC>
	<DOC>NCT00484757</DOC>
	<brief_summary>15 patients with narcolepsy and 15 healthy controls will be included in the study. According to a randomized, double-blind protocol they will receive intranasally at night first Orexine A and approximately two weeks later placebo or vice versa. Thereafter sleep will be recorded, the cytokine-system and neurocognition characterized.</brief_summary>
	<brief_title>Effect of Intranasal Administration of Orexine A on IL-6-System, Sleep-Wake-Regulation and Neurocognition</brief_title>
	<detailed_description />
	<mesh_term>Narcolepsy</mesh_term>
	<criteria>Narcolepsy Age &gt;18 Informed consent GERMAN fluently spoken Additional severe psychiatric or somatic disorders Pregnancy or nursing Anemia (Hb&lt;10g/dl)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>Narcolepsy</keyword>
	<keyword>Orexines</keyword>
	<keyword>sleep</keyword>
	<keyword>cognition</keyword>
	<keyword>cytokines</keyword>
</DOC>